0 Ratings

ID

23765

Description

Study part: Exploratory Biomarker Research Week 24.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

  1. 7/12/17 7/12/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 12, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Exploratory Biomarker Research Week 24 Mepolizumab HES NCT00086658

    Exploratory Biomarker Research Week 24

    EXPLORATORY BIOMARKER RESEARCH
    Description

    EXPLORATORY BIOMARKER RESEARCH

    Alias
    UMLS CUI-1
    C0005516 (Biological Markers)
    Has the subject provided written consent for exploratory biomarker research?
    Description

    informed consent biomarker

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430 (Informed Consent)
    UMLS CUI [1,2]
    C0005516 (Biological Markers)
    Date of Assessment Serum Biomarkers
    Description

    Date of Assessment Serum Biomarkers

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C2985720 (Assessment Date)
    UMLS CUI [1,2]
    C0229671 (Serum)
    SNOMED
    67922002
    LOINC
    LP18698-8
    UMLS CUI [1,3]
    C0005516 (Biological Markers)

    Similar models

    Exploratory Biomarker Research Week 24

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    EXPLORATORY BIOMARKER RESEARCH
    C0005516 (UMLS CUI-1)
    informed consent biomarker
    Item
    Has the subject provided written consent for exploratory biomarker research?
    boolean
    C0021430 (UMLS CUI [1,1])
    C0005516 (UMLS CUI [1,2])
    Date of Assessment Serum Biomarkers
    Item
    Date of Assessment Serum Biomarkers
    date
    C2985720 (UMLS CUI [1,1])
    C0229671 (UMLS CUI [1,2])
    C0005516 (UMLS CUI [1,3])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial